(2016) identified a link between enhanced Mes features in ESRP1‐low melanoma and high infiltrating lymphocyte activity, as assessed by a two‐gene signature (PRF1 encoding for perforin and GZMA encoding for granzyme A). The gene discussed is PRF1; the disease is melanoma.